Randomised Control Study to Asses the Role of Negative Pressure Wound Therapy (NPWT) in the Management of Wound in Surgical Patient
NCT ID: NCT02331485
Last Updated: 2015-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2014-08-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary outcome: Reduction in wound infection rate by 50%
Secondary outcome: Reduction of the length of hospital stay Decrease of using abx. for wound management Decrease cost of patient treatment
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Negative Pressure Wound Therapy for Wound Healing After Stoma Reversal
NCT03781206
Negative Pressure Wound Therapy to Reduce Surgical Site Infection
NCT01905397
Efficacy of NPWT in Reducing the Incidence of Wound Infection After Pancreatic Surgery
NCT03700086
Negative Pressure Incision Management System in Infrainguinal Vascular Surgery
NCT03395613
Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall.
NCT04960332
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are subgroups of patients with co-morbid conditions that put them at high risk of wound complications. These co-morbid conditions include increase BMI, known malignancy, diabetes mellitus, emergency surgery, malnutrition, smoking and diffuse atherosclerotic disease involving arteries. Management of these complicated wounds are a significant source of psychological trauma to patients and significantly increases hospital stay and cost.
Since its introduction, Negative Pressure Wound Therapy (NPWT) has been used mainly to deal with chronic wounds. Mechanism of action of NPWT includes protection of wound bed, splinting of soft tissues, reduction of oedema, increasing blood perfusion of wound and enhancing granulation tissue. Application of Negative Pressure Wound Therapy to prevent wound complications is a new concept, which has been successfully applied in acute wounds in orthopaedics, gynecological and cardiothoracic surgery patients.
There is limited data about the use of Negative Pressure Wound Therapy in high risk general surgical patients with acute wounds, but available studies suggest significant reduction in wound complication rate and hospital costs. There is a need for a randomised controlled study to assess the reduction of wound complication ratio.
Patient will be randomized to two groups:
Group 1. Standard wound treatment, Group 2. Treatment with negative pressure wound therapy (NPWT). If a patient is randomized to standard wound treatment group - he/she will receive standard skin closure and standard Mepore dressing, which will be changed on a daily basis.
Patients randomized to negative pressure group will received negative pressure dressing (Pico Wound Management System - manufacture by Smith \& Nephew) associated with Acticoat Flex dressing which will be applied immediately after skin closure in a conventional way and left in place for 7 days. Negative pressure dressing will be changed once during 7 days period - after day 2 to 4. Wound complications within first 30 days of surgery will be recorded on clinical examination.
Participants will be recruited from patients undergoing elective and emergency surgery in Connolly Hospital, Beaumont Hospital, St Vincent University Hospital and Mater Misericordiae University Hospital based on inclusion or exclusion criteria.
Inclusion criteria:
1. One from below:
* High BMI
* Malignancy
* Malnutrition
* T2 DM
* Emergency surgery
* Post radio chemotherapy
* On steroids
* Open colorectal resection
2. At least two from below:
* Smoking
* Age\>75
* Diffuse atherosclerotic disease involving arteries
Exclusion criteria:
* Low risk laparotomy wound (none of the above criteria)
* Age \< 18
Patient who fulfills inclusion criteria will be contacted prior to surgery by a research team member. Details of the study and risks and benefits will be explained to the patient. After obtaining consent the patient will be randomized to one of two groups - standard wound treatment or negative pressure treatment - by senior research team member. depending on the randomisation patient will recived appropriate dressing. Surgical wound will be asses on day 2 to 4, on day 7 and on day 30. Prior to first dressing application, after 2-4 days and on day 30 a wound swap will be obtain for C\&S. Any wound complication will be recorded in research evaluation form.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PICO + Acticoat group
Patients randomized to negative pressure group will received negative pressure dressing (Pico Wound Management System - manufacture by Smith \& Nephew) associated with Acticoat Flex dressing which will be applied immediately after skin closure in a conventional way and left in place for 7 days. Negative pressure dressing will be changed once during 7 days period - after day 2 to 4. Wound complications within first 30 days of surgery will be recorded on clinical examination.
PICO + Acticoat group
Comparison between Pico and Acticoat dressing change after 3 and 7 days with standard Mepor dressing change on daily basis.
Standard Wound management
If a patient is randomized to standard wound treatment group - he/she will receive standard skin closure and standard Mepore dressing, which will be changed on a daily basis.
PICO + Acticoat group
Comparison between Pico and Acticoat dressing change after 3 and 7 days with standard Mepor dressing change on daily basis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PICO + Acticoat group
Comparison between Pico and Acticoat dressing change after 3 and 7 days with standard Mepor dressing change on daily basis.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High BMI
* Malignancy
* Malnutrition
* T2 DM
* Emergency surgery
* Post radio chemotherapy
* On steroids
* Open colorectal resection
2. At least two from below:
* Smoking
* Age\>75
* Diffuse atherosclerotic disease involving arteries
Exclusion Criteria
* Age \< 18
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St James Connolly Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sebastian Smolarek
M.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sebastian K Smolarek, M.D
Role: PRINCIPAL_INVESTIGATOR
Connolly Hospital/Mater Misericordiae University Hospital
Thomas N Walsh, Professor, M.D, FRCSI
Role: STUDY_CHAIR
Connolly Hospital, Royal College of Surgeons in Ireland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Connolly Hospital
Dublin, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Lewis LS, Convery PA, Bolac CS, Valea FA, Lowery WJ, Havrilesky LJ. Cost of care using prophylactic negative pressure wound vacuum on closed laparotomy incisions. Gynecol Oncol. 2014 Mar;132(3):684-9. doi: 10.1016/j.ygyno.2014.01.014. Epub 2014 Jan 17.
Ousey KJ, Atkinson RA, Williamson JB, Lui S. Negative pressure wound therapy (NPWT) for spinal wounds: a systematic review. Spine J. 2013 Oct;13(10):1393-405. doi: 10.1016/j.spinee.2013.06.040. Epub 2013 Aug 24.
Hansen E, Durinka JB, Costanzo JA, Austin MS, Deirmengian GK. Negative pressure wound therapy is associated with resolution of incisional drainage in most wounds after hip arthroplasty. Clin Orthop Relat Res. 2013 Oct;471(10):3230-6. doi: 10.1007/s11999-013-2937-3.
Grauhan O, Navasardyan A, Hofmann M, Muller P, Stein J, Hetzer R. Prevention of poststernotomy wound infections in obese patients by negative pressure wound therapy. J Thorac Cardiovasc Surg. 2013 May;145(5):1387-92. doi: 10.1016/j.jtcvs.2012.09.040. Epub 2012 Oct 27.
Stoffan AP, Ricca R, Lien C, Quigley S, Linden BC. Use of negative pressure wound therapy for abdominal wounds in neonates and infants. J Pediatr Surg. 2012 Aug;47(8):1555-9. doi: 10.1016/j.jpedsurg.2012.01.014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NPWT Ireland
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.